Aims Lumen enlargement during repeat percutaneous coronary intervention for in-stent restenosis has been shown to be the result of both stent over-expansion and decrease in neointimal tissue. How these two different mechanisms of action may influence outcome and target lesion revascularization after repeat intervention for in-stent restenosis is unclear.
Introduction
The optimal treatment for in-stent restenosis is not clearly defined. For focal (<10 mm long) lesions, repeat balloon angioplasty has been shown to be safe [1] [2] [3] and efficient, with a recurrent restenosis rate as low as 14 to 31% [4, 5] . In addition, favourable late clinical outcome has also been shown after repeat balloon angioplasty in such lesions, with an event rate at 1 year ranging between 8 and 17% [5, 6] . Conversely, for non-selected in-stent restenotic lesions, including long (>10 mm) lesions, repeat balloon angioplasty has been shown to result in a high incidence of angiographic restenosis [4, 5] or clinical events [3, 6, 7] , thus prompting the use of alternative therapeutic options like debulking prior to balloon angioplasty, with laser, rotational or directional atherectomy [7] [8] [9] [10] [11] . To date, no technique has been shown to be superior. In a non-randomized report of 821 patients treated using balloon angioplasty, laser, rotational atherectomy or second stent placement, no difference in clinical outcome was found; the rate of lesion revascularization at 1 year being comprised between 23 and 31% [12] . Intravascular ultrasound imaging allows measurements of the lumen and stent cross-sectional areas and makes it possible to assess the mechanism and result of repeat angioplasty. The mechanism of lumen enlargement after repeat balloon angioplasty is a combination of both stent over-expansion and decrease in neointimal tissue within the stent [13, 14] of in-stent restenosis has the potential advantage of achieving larger lumen size post procedure than after balloon angioplasty alone, thanks to a greater decrease in neointimal tissue and less stent over-expansion [7, 10, 15] . Whether the mechanism of action, i.e. stent overexpansion or decrease in neointimal tissue area, can affect the late clinical outcome remains unclear. Hence, the aim of the study was to determine the impact of stent over-expansion and/or decrease in neointimal tissue on 1 year event-free survival post-repeat angioplasty for in-stent restenosis.
Methods

Study population
From June 1995 to October 1998, all patients submitted to repeat angioplasty for in-stent restenosis in coronary arteries were entered in a prospective registry. Clinical characteristics, angiographic data at stent implantation, at follow-up and at repeat angioplasty procedure were recorded. Only the patients in whom repeat angioplasty was performed under intravascular ultrasound guidance and who gave consent for clinical follow-up were considered for this study. Saphenous vein graft lesions were not considered in this study.
Repeat angioplasty
Two strategies were used for the repeat intervention: either balloon angioplasty or a combination of rotational atherectomy (Rotablator, Heart Technology Inc) and balloon angioplasty. The procedure selection was done according to the operator's choice, taking into account vessel size, the diameter stenosis and the length of the lesion. Thus, longer and more severe lesions were preferentially treated using rotational atherectomy and balloon angioplasty. For balloon angioplasty, semi compliant balloons were used (Viva Scimed or Calipso Bard), of the same size as at stent implantation. High inflation pressures were used (>10 atmospheres), without second stent placement. For rotational atherectomy and balloon angioplasty therapy, a multiple burr strategy was used to achieve a burr to artery ratio over 0·75. Intravascular ultrasound guidance for burr size selection was used in all cases; adjunctive balloon angioplasty was performed at the lowest balloon inflation pressure to achieve adequate angiographic and intravascular ultrasound results. No patient received GPII/IIIa inhibitors and all were discharged under a combination of aspirin and ticlopidine for 1 month.
Angiographic procedure and analysis
Before and after the procedure, angiography was performed for quantitative coronary angiography, using one single projection. Angiograms were analysed off-line using an automated edge detection algorithm (CAAS II, Pie Medical). The mean lumen diameter, the reference diameter, the percent of diameter stenosis and the length of the lesion were recorded.
Ultrasound procedure and analysis
Intravascular ultrasound imaging was carried out using a 30 MHz mechanical ultrasound transducer and an ultrasound scanner (Cardiovascular Imaging System, Inc). Images were recorded on an S-VHS videotape recorder during an automatic 0·5 cm/second pullback. Off line ultrasound analysis was carried out by a single observer using computer-assisted manual tracing (Echo Plaque, Indec systems). The selected measurement site was the image slice with the smallest lumen area and the most visible stent struts. At this level, the lumen crosssectional area and the stent cross-sectional area, were measured by manual planimetry using the hyperechogenic stent struts. The longitudinal reconstruction from images recorded during the automatic pullback was used to assess the distance between the measurement site and the distal edge of the stent. Measurements at the end of the procedure were repeated at the same distance from the distal edge of the stent. Neointimal tissue area within the stent was calculated as (stent cross-sectional area)-(lumen cross-sectional area). The stent over-expansion (Delta stent cross-sectional area) was calculated as (post-procedure stent cross-sectional area)-(pre-procedure stent cross-sectional area); similarly, the decrease in neointimal tissue within the stent (Delta neointimal tissue cross-sectional area) was calculated as (pre-procedure neointimal tissue crosssectional area)-(post-procedure neointimal tissue cross-sectional area). The reliability of intravascular ultrasound measurements has already been assessed and reported [14, 16] ; intra-class correlation coefficient (ratio of variance inter-patient over inter-patient variance plus intra-observer variance) of lumen crosssectional area measurements at stent level was 0·94 (mean difference standard deviation between two measurements=0·06 0·8 mm 2 ) and of stent crosssectional area was 0·93 (mean difference SD= 0·05 0·9 mm 2 ).
Clinical follow-up and definitions of events
The clinical follow-up was obtained up to 18 months after the intervention for in-stent restenosis. Follow-up information was obtained from the hospital records and telephone contact with the patient to determine the occurrence of major clinical events and symptoms level. Additional information was obtained from the referring physician. Angiographic control was performed in all patients with multiple vessel disease or in symptomatic patients. Death (whatever the cause), myocardial infarction, unstable angina, need for revascularization or
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recurrent angiographic restenosis were considered as an event. Definitions of these events were the same as those used in previous studies with clinical follow-up after repeat intervention [4] [5] [6] [7] [8] [9] 11, 13] .
Statistical analysis
Continuous data were presented as mean ( 1 standard deviation), qualitative data were presented as a percentage. Comparison between groups in qualitative data were made with Fisher's exact probabilities or with the likelihood ratio chi-square test and in continuous data with the Student t-test or the Mann-Whitney U test, when appropriate. Intra-individual comparison was done by the Wilcoxon signed rank test. Multivariate logistic regression analysis was used to identify predictors of clinical events after at least 3 months follow-up (variables with a P value <0·10 by univariate analysis were entered into the multivariate analysis). Discriminant analysis was used to determine cut-off points in predictive variables for events, and event-free survival curves were compared using the Mantel Cox test. A P<0·05 was considered significant. Statistical analysis was performed with BMDP 90 statistical software (University of California, Berkeley, CA, U.S.A.).
Results
Study population
One hundred and thirty three patients were entered in the registry. In 63, repeat angioplasty for in-stent restenosis was carried out without intravascular ultrasound imaging and these patients were not taken into account in this study. Seventy patients were submitted to repeat angioplasty for in-stent restenosis, with angiographic and intravascular ultrasound imaging before and after the procedure. The comparison of the clinical presentation of the 70 patients of the study population and patients from the registry, not included in the study, showed no difference ( Table 1) . The indications for stent implantation were: (1) suboptimal result after balloon angioplasty in 43 (61%); (2) C or D type dissection in 16 (23%); (3) as an elective policy in acute myocardial infarction in seven (10%) and (4) Angiographic data at the time of the stent deployment are presented in Table 2 . Stents were deployed using high pressure balloon inflation (more than 12 atmospheres). Angiographic mean lumen diameter at the time of stent implantation was 2·30 0·42 mm. All patients received a combination of aspirin and ticlopidine for 1 month.
Repeat angiography was carried out because of recurrence of symptoms in 35 (50%), silent ischaemia detected by stress test in 16 (23%) or systematic angiographic control in 19 (27%) and showed a >50% diameter stenosis assessed by quantitative coronary angiography at stent level. Two patients had a total chronic occlusion and five patients had recurrent restenosis after balloon angioplasty for in-stent restenosis. The mean time-interval between stent implantation and repeat procedure was 166 78 days.
Repeat angioplasty procedure
The angiographic and intravascular ultrasound measurements before the procedure are presented in Table 3 . The result of our routine policy was that, compared to those treated by balloon angioplasty alone, the patients in the rotational atherectomy and balloon angioplasty group had a smaller angiographic mean lumen diameter (0·73 0·28 vs 0·98 0·31 mm, P< 0·001), a smaller lumen cross-sectional area (1·6 0·7 vs 2·0 0·9 mm 2 , P=0·03), longer lesions (12·7 7·4 vs 8·0 3·7 mm, P=0·001) and a smaller reference vessel diameter (2·53 0·44 vs 2·77 0·44 mm, P=0·04). A greater amount of neointimal tissue was observed, before repeat intervention, in the rotational atherectomy and balloon angioplasty group (5·9 1·7 vs 4·9 2·1 mm 2 , P=0·02) The procedural characteristics of repeat intervention are presented in Table 4 . The result of the repeat procedure was an increase in angiographic mean lumen diameter of 1·10 0·42 mm (P<0·001) and an increase in intravascular ultrasound lumen cross-sectional area of 3·1 1·4 mm 2 (P<0·001). This lumen enlargement was obtained by a significant stent over-expansion (Delta stent cross-sectional area=2·2 2·0 mm 2 , P<0·001) and by an adjunctive decrease in neointimal tissue area (Delta neointimal tissue cross-sectional area =1·3 2·1 mm 2 , P<0·001). The two variables were normally distributed; median was 2·2 mm 2 for Delta stent cross-sectional area (range 0·4-9·8), and 1·4 mm 2 for Delta neointimal tissue cross-sectional area (range 0-13). The cumulative curves of lumen cross-sectional area and stent cross-sectional area before and after repeat procedure are presented in Fig. 1 
Clinical follow-up
Fourteen patients (20%) had an event during follow-up. The median follow-up time was 166 days (range 120 to Table 2 Angiographic data before and after initial angioplasty
Variables n=70
Reference diameter pre PTCA (mm)
Pre-PTCA=before initial angioplasty; post stent=after stent implantation. 
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900 in the group without event, and 60 to 225 in the group with event). Two patients died, one from sudden death and one from stroke. Twelve patients had recurrence of angina and angiographic restenosis; four were referred for surgical revascularization, seven had repeat angioplasty and one had medical therapy. The eventfree survival curve is presented in Fig. 2 , event-free probability at 1 year was 0·76 0·05. Tables 2 and 3 . HSRA+B=patients treated using a combination of rotational atherectomy and balloon angioplasty; *P value by Student t-test; **P value by Mann-Whitney U test; ***P value <0·05 by Wilcoxon test. Delta S-CSA=increase in S-CSA after the repeat angioplasty; Delta T-CSA=decrease in T-CSA. 
Predictors of clinical events
1·8 1·9 mm
2 , P=0·25). Conversely, the lumen crosssectional area and the percent of neointimal tissue within the stent after repeat intervention were significantly different between groups. The Delta stent cross-sectional area, Delta neointimal tissue cross-sectional area, lumen cross-sectional area, neointimal tissue cross-sectional area/stent cross-sectional area were entered into the multivariate analysis, as well as the type of procedure, the angiographic final mean lumen diameter and the initial lesion length, since these variables were found to be predictors in other studies. As a result, in our population, the only independent predictor of event-free survival was the lumen cross-sectional area, the odds ratio was 4·5 (95% confidence interval=[1·1;18], P=0·03) per additional mm 2 . The cut-off point of the lumen cross-sectional area was determined at 4·7 mm 2 by discriminant analysis. Using the jack-knife procedure, 62% of the patients were properly classified (with or without event) according to a post repeat angioplasty lumen cross-sectional area greater or smaller than 4·7 mm 2 . In the study population, 35 patients had a lumen cross-sectional area larger than 4·7 mm 2 and 35 smaller than 4·7 mm 2 . The event-free survival curves of these two groups are displayed in Fig. 3 ; event-free survival cumulative probability was 69 15% in patients with <4·7 mm 2 lumen cross-sectional area and 91 8% in patients with >4·7 mm 2 lumen cross-sectional area (P=0·008 by Mantel-Cox test).
Discussion
In this study, the clinical outcome after angioplasty for in-stent restenosis was not related to the mechanism of lumen enlargement, but rather the lumen cross-sectional area, assessed at the end of the repeated angioplasty.
Aim and design of the study
Intravascular ultrasound imaging makes it possible to determine the mechanism of lumen enlargement after angioplasty for in-stent restenosis; stent over-expansion and decrease of neointimal tissue within the stent [13] . After balloon angioplasty, both mechanisms play equal parts in lumen enlargement [13, 14] , but less stent overexpansion and more decrease of tissue within the stent is observed after a combination of debulking and balloon than after balloon alone [15] . In our study, all patients treated under intravascular ultrasound imaging were eligible for this longitudinal and observational cohort study; 40 were treated using balloon angioplasty and 30 using rotational atherectomy and balloon angioplasty. Use of the two different types of procedure resulted in a wide range of stent over-expansion (average 2·2 2·0 mm 2 , range [0·4-9·8]) and a decrease in tissue (average 1·3 2·1 mm 2 , range [0-13]).
Procedure selection and immediate results
The type of procedure was selected according to the operator's choice, based on the angiographic on-line aspect. As a result, the group treated by rotational atherectomy and balloon angioplasty was composed of patients with longer lesions and smaller mean lumen diameter and lumen cross-sectional area. At the end of the procedure, there was no difference in mean lumen diameter or lumen cross-sectional area between the two treatment groups, as the higher immediate gain compensated for the more severe lesions in the rotational atherectomy and balloon angioplasty group. As expected, the group treated by balloon alone had greater stent over-expansion (2·4 1·6 mm 2 vs 1·9 2·0 mm 2 , 
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P=0·03) and a smaller decrease in neointimal tissue area (0·7 2·2 mm 2 vs 2·1 2·1 mm 2 , P=0·01) than the patients treated by rotational atherectomy and balloon angioplasty. This difference in the mechanism of lumen enlargement is in agreement with previous studies [7, 10, 15, 17] .
Lesion length and clinical outcome
In our study, the 1 year event-free survival probability was 76 5% corresponding to a global 20% event rate, and a 25% event rate in the subgroup of patients treated by balloon alone. This is similar to previous reports of event rates ranging from 14% to 46% after balloon angioplasty, with lesion length being the constant predictive factor of long term outcome [5, 7, 13] . In studies using rotational atherectomy and balloon angioplasty, clinical event rates between 19% and 35% have been reported, with this rate also depending on the lesion length [7, 8, 18] . In our study, however, only 13% of patients treated by rotational atherectomy and balloon angioplasty had a clinical event, although admittedly, the average lesion length in our population was relatively short, at only 12·7 7·4 mm. Several studies have shown a better clinical outcome after a debulking strategy than after balloon angioplasty [7, 8, 10, 11, 13] , and even though the present study did not aim to compare the two types of procedure, we cannot ignore the fact that a nonsignificant trend toward better clinical outcome was observed after rotational atherectomy and balloon angioplasty than after balloon (the event rate was, respectively, 13% vs 25%, P=0·22) and this, despite longer lesions in rotational atherectomy and balloon angioplasty group.
Predictors of event-free survival
Neither the decrease in neointimal tissue area within the stent, nor the extent of stent over-expansion was found to be a predictor of a clinical event and therefore, the hypothesis of the study was not confirmed. In fact, the only independent predictor of event-free survival was the lumen cross-sectional area measured at the end of the repeat intervention, with an odds ratio of 4·5 per additional mm 2 . This tends to demonstrate that only the final lumen size after repeat angioplasty has an impact on the clinical outcome, no matter what the mechanism of lumen enlargement. Thus the only potential benefit for the use of atherectomy prior to balloon angioplasty could be the higher lumen gain. The importance of achieving maximal lumen size was illustrated by the significant difference in event-free survival of patients with more vs less than 4·7 mm 2 in the final lumen cross-sectional area. These findings are in agreement with other reports where the lumen size, expressed by the angiographic mean lumen diameter, was also a predictor of a clinical event [8, 9, 13] or recurrent restenosis [16] . Conversely, these findings may not be valid in cases of second stent placement, even if a larger lumen size is achieved [12] . It is likely that major vessel stretching occurs in cases of second stent implantation, resulting in neointimal proliferation, as demonstrated after a first stent implantation [19] .
Clinical implications
The favourable clinical outcome of the patients with a final lumen cross-sectional area larger than 4·7 mm 2 suggests that when this is achieved, no adjunctive therapy is necessary. On the other hand, a population at high risk of clinical events after repeat intervention, namely patients with only a small lumen area at the end of the repeat procedure, could be selected by intravascular ultrasound. In these patients, adjunctive therapeutic options, such as coronary radiation could be considered.
Study limitations
(1) Only patients treated with intravascular ultrasound imaging were included in this study. (2) Only a few patients with very diffuse in-stent restenosis were included in the study. (3) This study was not designed to compare the two strategies for repeat angioplasty, since it was not randomized and the longer and the more severe lesions were generally treated using rotational atherectomy. (4) Patients with second stent placement were not included in this study. (5) Only clinical outcome was considered in this study, without systematic angiographic control. 400 600 800 0 <4·7 mm 2 : EFS probability = 0·69 ± 0·15 >4·7 mm 2 : EFS probability = 0·91 ± 0·08 P = 0·008* Figure 3 One year event-free survival curves according to the post procedure lumen cross-sectional area (> or <4·7 mm 2 ). EFS=event-free survival; =patients with a final lumen cross-sectional area <4·7 mm 2 (n=35), =patients with final lumen cross-sectional area >4·7 mm 2 (n=35), *P value using Mantel Cox test.
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Conclusions
This observational study did not confirm that stent over-expansion or extent of remaining tissue have any influence on the second restenosis process, and eventually on late clinical outcome. The main finding of this study was that the only independent predictor of late clinical outcome was final lumen size, no matter what the means used to achieve it.
